- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
H4B.2: 13 residues within 4Å:- Chain A: S.65, V.67, R.328, A.409, W.410
- Chain B: W.408, F.423, H.424, Q.425, E.426
- Ligands: HEM.1, X2D.3, GOL.5
7 PLIP interactions:1 interactions with chain B, 6 interactions with chain A- Hydrophobic interactions: B:E.426
- Hydrogen bonds: A:R.328, A:A.409, A:W.410
- Water bridges: A:R.328
- pi-Stacking: A:W.410, A:W.410
H4B.9: 13 residues within 4Å:- Chain A: W.408, F.423, H.424, Q.425, E.426
- Chain B: S.65, V.67, R.328, A.409, W.410
- Ligands: HEM.8, X2D.10, GOL.12
8 PLIP interactions:7 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.328, B:A.409, B:W.410
- Water bridges: B:E.324, B:R.328
- pi-Stacking: B:W.410, B:W.410
- Hydrophobic interactions: A:E.426
- 2 x X2D: 6-{[(3R,4R)-4-(2-{[(1R,2S)-2-(3-chlorophenyl)cyclopropyl]amino}ethoxy)pyrrolidin-3-yl]methyl}-4-methylpyridin-2-amine(Non-covalent)
X2D.3: 17 residues within 4Å:- Chain A: V.67, R.146, Q.210, P.297, V.299, F.316, S.317, G.318, W.319, Y.320, E.324, W.410, Y.438
- Chain B: W.37
- Ligands: HEM.1, H4B.2, GOL.5
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:V.67, A:P.297, A:P.297, A:V.299, A:Y.320, A:Y.438, A:Y.438, B:W.37
- Hydrogen bonds: A:R.146, A:E.324
- Water bridges: A:Q.210, A:Q.210
X2D.10: 16 residues within 4Å:- Chain A: W.37
- Chain B: V.67, L.68, R.146, Q.210, P.297, V.299, F.316, G.318, W.319, E.324, W.410, Y.438
- Ligands: HEM.8, H4B.9, GOL.12
10 PLIP interactions:9 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:V.67, B:L.68, B:P.297, B:P.297, B:Y.438, B:Y.438, A:W.37
- Hydrogen bonds: B:R.146, B:E.324
- Water bridges: B:Q.210
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 5 residues within 4Å:- Chain A: G.149, I.151, W.319, V.381, S.389
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.151
- Hydrogen bonds: A:W.319, A:S.389
ACT.11: 6 residues within 4Å:- Chain B: G.149, I.151, W.319, V.381, S.389
- Ligands: HEM.8
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.389, B:S.389
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 5 residues within 4Å:- Chain A: R.328, H.334
- Chain B: W.37
- Ligands: H4B.2, X2D.3
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.328, A:R.328, A:H.334
GOL.12: 6 residues within 4Å:- Chain A: W.37
- Chain B: V.67, R.328, H.334
- Ligands: H4B.9, X2D.10
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.328, B:R.328, B:H.334
- Water bridges: B:D.332, A:H.424
- 2 x CAD: CACODYLIC ACID(Non-covalent)
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, H. et al., Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase. Bioorg.Med.Chem. (2013)
- Release Date
- 2012-05-02
- Peptides
- Nitric oxide synthase, endothelial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
- 2 x X2D: 6-{[(3R,4R)-4-(2-{[(1R,2S)-2-(3-chlorophenyl)cyclopropyl]amino}ethoxy)pyrrolidin-3-yl]methyl}-4-methylpyridin-2-amine(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 2 x CAD: CACODYLIC ACID(Non-covalent)
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, H. et al., Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase. Bioorg.Med.Chem. (2013)
- Release Date
- 2012-05-02
- Peptides
- Nitric oxide synthase, endothelial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B